1. Home
  2. MRKR vs FEBO Comparison

MRKR vs FEBO Comparison

Compare MRKR & FEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRKR
  • FEBO
  • Stock Information
  • Founded
  • MRKR N/A
  • FEBO 1993
  • Country
  • MRKR United States
  • FEBO Hong Kong
  • Employees
  • MRKR N/A
  • FEBO N/A
  • Industry
  • MRKR Biotechnology: Pharmaceutical Preparations
  • FEBO
  • Sector
  • MRKR Health Care
  • FEBO
  • Exchange
  • MRKR Nasdaq
  • FEBO Nasdaq
  • Market Cap
  • MRKR 21.9M
  • FEBO 19.4M
  • IPO Year
  • MRKR N/A
  • FEBO 2023
  • Fundamental
  • Price
  • MRKR $2.16
  • FEBO $1.47
  • Analyst Decision
  • MRKR Strong Buy
  • FEBO
  • Analyst Count
  • MRKR 1
  • FEBO 0
  • Target Price
  • MRKR $19.00
  • FEBO N/A
  • AVG Volume (30 Days)
  • MRKR 53.9K
  • FEBO 57.8K
  • Earning Date
  • MRKR 11-14-2024
  • FEBO 10-03-2024
  • Dividend Yield
  • MRKR N/A
  • FEBO N/A
  • EPS Growth
  • MRKR N/A
  • FEBO N/A
  • EPS
  • MRKR N/A
  • FEBO N/A
  • Revenue
  • MRKR $5,395,849.00
  • FEBO $16,319,897.00
  • Revenue This Year
  • MRKR $64.48
  • FEBO N/A
  • Revenue Next Year
  • MRKR N/A
  • FEBO N/A
  • P/E Ratio
  • MRKR N/A
  • FEBO N/A
  • Revenue Growth
  • MRKR 79.04
  • FEBO 9.01
  • 52 Week Low
  • MRKR $1.83
  • FEBO $1.20
  • 52 Week High
  • MRKR $5.99
  • FEBO $17.68
  • Technical
  • Relative Strength Index (RSI)
  • MRKR 32.84
  • FEBO 41.24
  • Support Level
  • MRKR $1.83
  • FEBO $1.54
  • Resistance Level
  • MRKR $2.79
  • FEBO $1.72
  • Average True Range (ATR)
  • MRKR 0.28
  • FEBO 0.21
  • MACD
  • MRKR -0.09
  • FEBO -0.00
  • Stochastic Oscillator
  • MRKR 21.02
  • FEBO 8.20

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.

About FEBO Fenbo Holdings Limited

Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.

Share on Social Networks: